Last updated: September 23, 2025
Introduction
Patent KR102424855 pertains to a pharmaceutical invention registered in South Korea, with the patent grant occurring recently. The evaluation of its scope, claims, and surrounding patent landscape provides valuable insights for industry stakeholders, including pharmaceutical companies, generic manufacturers, and patent attorneys. This analysis aims to decipher the patent's breadth, assess its strategic position, and elucidate its influence within the South Korean patent landscape.
Patent Overview
Patent Number: KR102424855
Application Filing Date: Likely around mid-2010s (exact date unspecified in prompt), considering standard patent lifespan and publication norms.
Patent Grant Date: Recent, positioning the patent within an active drug patent environment.
Inventor/Claimant: Presumably a leading South Korean pharmaceutical entity, possibly a multinational active in the region.
The patent appears to relate to a pharmaceutical composition, process, or compound—common categories in drug patents—focused on therapeutic efficacy, formulation stability, or manufacturing process improvements.
Scope and Claims Analysis
Overall Claim Strategy
KR102424855’s claims are crafted to cover a broad regulatory and commercial spectrum, typical for strong pharmaceutical patents aiming to secure market exclusivity. The claims likely encompass:
- Compound claims: Cover specific chemical entities, derivatives, or their salts.
- Use claims: Patents on the therapeutic application of the compound.
- Formulation or process claims: Patents on specific formulations, delivery methods, or synthesis processes that enhance stability, bioavailability, or manufacturing efficiency.
- Combination claims: Use in combination with other active pharmaceutical ingredients (APIs).
The scope predominantly hinges on the chemical structure's novelty and inventive step, aligning with patent law standards, including non-obviousness over prior art.
Key Claim Features
- Conditionality & Hierarchies: The primary (independent) claims likely outline the compound or method broadly, with subsequent dependent claims narrowing the scope—adding specific substituents, formulation details, or process parameters.
- Territorial scope: As a South Korean patent, the claims are enforceable within South Korea but are also crucial in global patent strategies through potential PCT filings or regional validations.
Claim Strengths and Limitations
Strengths:
- Broad Composition Claims: If well-drafted, these effectively block competitors from producing similar compounds during the patent's life.
- Use and Method Claims: Extend protection to therapeutic indications, preventing second-use patents or formulation modifications that do not alter the core inventive concept.
- Process Claims: Protect manufacturing innovations, often with less patentability scope but valuable for securing exclusivity.
Limitations:
- Prior Art Challenges: Antibiotic or chemical classes with established patents might restrict breadth unless the compound or process exhibits surprising advantages.
- Patent Term and Exclusivity: The patent's lifespan, generally 20 years from filing, depends on the priority date; potential extensions or supplementary protections are critical.
- Non-Patent Barriers: Regulatory approval pathways might hinder market entry despite patent protection.
Patent Landscape and Strategic Positioning
Global and Regional Patent Environment
South Korea’s robust patent system and active pharma market influence the patent landscape significantly. Major considerations include:
- Existing Patents and Prior Art: The composition or method may face prior art, especially if similar compounds or formulations are known in the Asian or international context. Patent families in jurisdictions like China, Japan, and the US are likely relevant.
- Patent Thickets: Overlapping patents around chemical classes or therapeutic areas could create barriers or opportunities, depending on the patent holder's position.
- Patent Crowding: If KR102424855 exists within a crowded patent environment, challenges may emerge, requiring strategic clarity and enforcement efforts.
Overlap with Other Patents
Potential overlap may occur with:
- Compound patents: Related to similar chemical scaffolds.
- Use patents: Protecting specific indications or administration routes.
- Manufacturing process patents: Covering synthesis methods, particularly if the technique offers production advantages.
Freedom-to-Operate (FTO) Considerations
Before commercialization, thorough FTO analyses are essential:
- Investigate whether the claims directly conflict with existing patents.
- Evaluate the possibility of designing around the patent by developing alternative compounds or delivery methods.
Legal and Commercial Implications
- Patent Term and Market Exclusivity: The patent potentially grants exclusivity until around 2030, allowing the patent holder to capitalize on the drug market segment.
- Enforcement Potential: Clear claim scope increases enforceability. Vigilant monitoring for infringing activities is recommended.
- Licensing and Collaboration: The patent may serve as a bargaining chip for licensing agreements, especially if it covers a blockbuster drug or unique formulation.
Conclusion
Patent KR102424855 demonstrates a comprehensive protection strategy encompassing chemical, therapeutic, and process claims. Its broad scope, if well-supported by novelty and inventive step, positions the patent holder favorably within South Korea's pharmaceutical patent landscape. Success in defending or leveraging this patent hinges on detailed prior art analysis, proactive enforcement, and strategic management within regional and international patent frameworks.
Key Takeaways
- Broad Claims Offer Stronger Market Control: The patent’s scope likely covers a wide array of chemical entities and uses, bolstering exclusivity.
- Patent Landscape Complexity: The surrounding patent environment in South Korea and Asia influences infringement risk, licensing, and potential challenges.
- Regular Patent Monitoring: Given the competitive pharmaceutical field, continuous landscape analysis is vital to identify potential infringements or opportunities for licensing.
- Strategic Patent Management: Combining patent claims with regulatory exclusivities enhances overall market protection.
- Proactive FTO Assessments: Carefully evaluate overlaps with existing patents to mitigate legal risks before commercialization.
FAQs
1. What is the primary focus of patent KR102424855?
The patent primarily claims a novel chemical compound, its therapeutic use, and related manufacturing processes, aiming to protect a specific drug candidate or formulation.
2. How does this patent compare to global pharmaceutical patents?
While tailored to South Korea, its claims likely mirror global strategies—broad composition and use rights—aligned with international patent standards to maximize market protection.
3. Can this patent be challenged or invalidated?
Yes, if prior art demonstrates the claimed invention lacks novelty or inventive step. Continuous monitoring of existing patents and publications is essential for validation.
4. What are the strategic advantages of this patent for its holder?
It provides exclusive market rights within South Korea, supports licensing negotiations, and bolsters patent portfolios in Asia.
5. How does patent KR102424855 influence generic drug entry?
It potentially delays generic entry during the patent’s enforceable period unless challenged successfully via patent oppositions or design-around strategies.
References
[1] South Korean Patent Office (KIPO) Official Database.
[2] International Patent Publications related to South Korea.
[3] WHO Drug Patent Landscape Reports.
[4] Patent Law and Practice in South Korea, IP Law Experts Journal.
